Media coverage
17
Media coverage
Title Targovax Announces That The ONCOS-102 And Durvalumab Trial Successfully Completes Part 1 In Colorectal Cancer Media name/outlet TheStreet.com Country/Territory United States Date 13/10/20 URL https://www.thestreet.com/press-releases/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer-15456473 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet PR Newswire Country/Territory United States Date 13/10/20 URL https://www.prnewswire.com/news-releases/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer-301150766.html Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Morningstar.com Country/Territory United States Date 13/10/20 URL https://www.morningstar.com/news/pr-newswire/20201013io56334/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Yahoo! Finanzas Country/Territory United States Date 13/10/20 URL https://es-us.finanzas.yahoo.com/news/targovax-announces-oncos-102-durvalumab-052400966.html Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet TickerTech.com Country/Territory United States Date 13/10/20 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202010202010130124PR_NEWS_USPR_____IO56334 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Finanzen.net Country/Territory Germany Date 13/10/20 URL https://www.finanzen.net/nachricht/aktien/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer-9384671 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Finanzen.ch Country/Territory Switzerland Date 13/10/20 URL https://www.finanzen.ch/nachrichten/aktien/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer-1029672225 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Market Newsdesk Country/Territory United States Date 13/10/20 URL www.marketnewsdesk.com/?p=355875 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Wallstreet Online Country/Territory Germany Date 13/10/20 URL https://www.wallstreet-online.de/nachricht/13023876-targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-colorectal-cancer Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Markets Business Insider Country/Territory United States Date 13/10/20 URL www.quotenet.com/news/stocks/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer-1029672225 Persons Dmitriy Zamarin Title $AZN Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet OTC Dynamics Country/Territory Canada Date 13/10/20 URL https://www.otcdynamics.com/azn-targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer/ Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Crwe World Country/Territory United States Date 13/10/20 URL crweworld.com/article/news-provided-by-pr-newswire/1726742/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet BioSpace Country/Territory United States Date 13/10/20 URL https://www.biospace.com/article/releases/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer/ Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Cision News Country/Territory United States Date 13/10/20 URL https://news.cision.com/targovax/r/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorect,c3214711 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet WFMZ-TV Online Country/Territory United States Date 13/10/20 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal/article_2ceb454c-e7e0-5440-869b-eacc7cbfed8c.html Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet VB Profiles Country/Territory United States Date 13/10/20 URL https://www.vbprofiles.com/press_releases/5f853cd6b9abe402072ad6f8 Persons Dmitriy Zamarin Title Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer Media name/outlet Central Charts Country/Territory France Date 13/10/20 URL https://www.centralcharts.com/en/1928296-targovax-as-cboe/news/2840001-targovax-announces-that-the-oncos-102-and-durvalumab-trial-successfully-completes-part-1-in-colorectal-cancer Persons Dmitriy Zamarin